Cargando…
Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22
In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections wer...
Autores principales: | Melidou, Angeliki, Ködmön, Csaba, Nahapetyan, Karen, Kraus, Annette, Alm, Erik, Adlhoch, Cornelia, Mooks, Piers, Dave, Nishi, Carvalho, Carlos, Meslé, Margaux MI, Daniels, Rodney, Pebody, Richard, Tabain, Irena, Botnen, Amanda Bolt, Trebbien, Ramona, Ikonen, Niina, Lyytikäinen, Outi, Wedde, Marianne, Dürrwald, Ralf, Bennett, Charlene, Connell, Jeff, Puzelli, Simona, Facchini, Marzia, Meijer, Adam, Fouchier, Ron A.M., Vukovikj, Maja, Janchevska, Elizabeta, Bragstad, Karoline, Hungnes, Olav, Komissarov, Andrey, Stolyarov, Kirill, Pozo, Francisco, Casas, Inmaculada, Gonçalves, Ana Rita, Spedaliero, Tania, Moore, Catherine, Cottrell, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012087/ https://www.ncbi.nlm.nih.gov/pubmed/35426364 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.15.2200255 |
Ejemplares similares
-
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 – impact of the COVID-19 pandemic
por: Melidou, Angeliki, et al.
Publicado: (2020) -
Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018) -
Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63
por: Moen, Line Victoria, et al.
Publicado: (2022) -
Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2021) -
Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022
por: Vikse, Elisabeth Lea, et al.
Publicado: (2023)